Wednesday, May 03, 2017 8:09:36 AM
Consensus Ratings for Bristol-Myers Squibb Co (NYSE:BMY)
Ratings Breakdown: 11 Hold Ratings, 9 Buy Ratings
Consensus Rating: Hold (Score: 2.45)
Consensus Price Target: $62.35 (11.44% upside)
https://www.marketbeat.com/stocks/NYSE/BMY/
Eyeballing a 3 year chart looks to me to be low to mid $60's. Pretty crude but they jibe:
I don't see an imminent buyout despite the informational posts regarding such speculation.
What is your take?
BMY
Recent BMY News
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
